Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKRLX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $32,499.90 for Stelara 90 mg/ml syringes. The contract, awarded on July 31, 2025, with an ultimate completion date of August 21, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing $500 million Indefinite Delivery Contract with the DLA under the SPE2DB program, which extends through November 2026 and authorizes the issuance of firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Stelara is a biologic immunosuppressant medication primarily used to treat autoimmune conditions, and this delivery order represents a routine replenishment of the drug for Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contracts covering branded and generic prescription drugs, biologics, and specialty medications to military and federal healthcare systems. The company's ability to consistently secure contracts reflects its operational strength as a pharmaceutical wholesaler and effective positioning within federal procurement markets.
Quick answers
Who was awarded contract SPE2DB25FKRLX?
SPE2DB25FKRLX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FKRLX worth?
The government has obligated $32,500 on SPE2DB25FKRLX.
Is contract SPE2DB25FKRLX an order under another contract?
Yes. SPE2DB25FKRLX is a delivery order under SPE2DB24D9314, an indefinite delivery contract.
Was contract SPE2DB25FKRLX competed?
The extent of competition for SPE2DB25FKRLX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award